MYOCET

This brand name is authorized in Austria, Cyprus, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland, Romania

Active ingredients

The drug MYOCET contains one active pharmaceutical ingredient (API):

1 Doxorubicin UNII 82F2G7BL4E - DOXORUBICIN HYDROCHLORIDE

Doxorubicin is a cytotoxic anthracycline antibiotic obtained from Streptomyces peucetius var. caesius. The exact mechanism of the antitumour activity of doxorubicin is not known. It is generally believed that inhibition of DNA, RNA and protein synthesis is responsible for the majority of the cytotoxic effects. Read about Doxorubicin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01DB01	Doxorubicin	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01D Cytotoxic antibiotics and related substances → L01DB Anthracyclines and related substances
Discover more medicines within L01DB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1212398, 1598003
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 00141001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 003099
Country: FR	Base de données publique des médicaments	Identifier(s): 68974273
Country: IT	Agenzia del Farmaco	Identifier(s): 035189012
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1029920, 1065432
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 77984
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100133608
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W69351001